This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shiozawa, T. Articles by Nikaido, T. Search for Related Content PubMed PubMed Citation Articles by Shiozawa, T. Articles by Nikaido, T. Pubmed/NCBI databases Substance via MeSH

Up-Regulation of p27Kip1 by Progestins Is Involved in the Growth Suppression of the Normal and Malignant Human Endometrial Glandular Cells

Department of Obstetrics and Gynecology (T.S., A.H., K.K., M.O., I.K., T.N.), Shinshu University School of Medicine, Matsumoto 390-8621, Japan; Department of Gynecology and Obstetrics (S.F.), Faculty of Medicine, Kyoto University, Kyoto 606-8507, Japan; and Department of Organ Regeneration (T.N.), Shinshu University Graduate School of Medicine, Matsumoto 390-8621, Japan

Address all correspondence and requests for reprints to: Toshio Nikaido, Ph.D., Department of Obstetrics and Gynecology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan. E-mail: tnikaido{at}hsp.md.shinshu-u.ac.jp

Progestins are known to suppress the growth of normal human endometrial glands and endometrial carcinomas possessing PRs. To elucidate the molecular mechanisms of progestin-induced growth inhibition, the expression and functional involvement of p27Kip1 (p27), a cyclin-dependent-kinase inhibitor, was investigated using cultured normal endometrial glandular cells and endometrial carcinoma cell lines (Ishikawa; PR-positive, KLE; PR-negative). Growth of the normal endometrial glandular cells and Ishikawa cells was suppressed by treatment with progesterone and medroxyprogesterone acetate, respectively, in association with an increase in p27 protein expression. Immunoprecipitation revealed that progestins accelerated the complex formation of p27 and cdk2 in both types of cells. However, treatment with progestins did not show any marked alterations in the mRNA expression of p27 in either normal glandular cells or Ishikawa cells. On the other hand, p27 protein degradation experiments indicated that treatment with progesterone and medroxyprogesterone acetate prolonged the degradation time of the normal endometrial glandular cells and Ishikawa cells, respectively. Forced expression of the p27 protein using a p27 expression plasmid reduced the growth activity of normal endometrial glandular cells. These findings suggest that p27 is functionally involved in progestin-induced growth suppression of normal and malignant endometrial epithelial cells and that up-regulation of the p27 protein by progestins possibly occurs via posttranslational mechanisms.

This article has been cited by other articles:

				C. Bellehumeur, J. Blanchet, J.-Y. Fontaine, N. Bourcier, and A. Akoum Interleukin 1 regulates its own receptors in human endometrial cells via distinct mechanisms Hum. Reprod., May 28, 2009; (2009) dep192v1. [Abstract] [Full Text] [PDF]

				H. KASHIMA, A. HORIUCHI, J. UCHIKAWA, T. MIYAMOTO, A. SUZUKI, T. ASHIDA, I. KONISHI, and T. SHIOZAWA Up-regulation of Nuclear Receptor Corepressor (NCoR) in Progestin-induced Growth Suppression of Endometrial Hyperplasia and Carcinoma Anticancer Res, April 1, 2009; 29(4): 1023 - 1029. [Abstract] [Full Text] [PDF]

				H. Kashima, T. Shiozawa, T. Miyamoto, A. Suzuki, J. Uchikawa, M. Kurai, and I. Konishi Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E Endocr. Relat. Cancer, March 1, 2009; 16(1): 113 - 122. [Abstract] [Full Text] [PDF]

				R. S. Usadi, J. M. Groll, B. A. Lessey, R. A. Lininger, R. J. Zaino, M. A. Fritz, and S. L. Young Endometrial Development and Function in Experimentally Induced Luteal Phase Deficiency J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 4058 - 4064. [Abstract] [Full Text] [PDF]

				J. Lecanda, T. V. Parekh, P. Gama, K. Lin, V. Liarski, S. Uretsky, K. Mittal, and L. I. Gold Transforming Growth Factor-{beta}, Estrogen, and Progesterone Converge on the Regulation of p27Kip1 in the Normal and Malignant Endometrium Cancer Res., February 1, 2007; 67(3): 1007 - 1018. [Abstract] [Full Text] [PDF]

				T. Miyamoto, T. Shiozawa, H. Kashima, Y.-Z. Feng, A. Suzuki, M. Kurai, T. Nikaido, and I. Konishi Estrogen Up-Regulates Mismatch Repair Activity in Normal and Malignant Endometrial Glandular Cells Endocrinology, October 1, 2006; 147(10): 4863 - 4870. [Abstract] [Full Text] [PDF]

				D. Palmieri, D. O. Halverson, T. Ouatas, C. E. Horak, M. Salerno, J. Johnson, W. D. Figg, M. Hollingshead, S. Hursting, D. Berrigan, et al. Medroxyprogesterone Acetate Elevation of Nm23-H1 Metastasis Suppressor Expression in Hormone Receptor-Negative Breast Cancer J Natl Cancer Inst, May 4, 2005; 97(9): 632 - 642. [Abstract] [Full Text] [PDF]

				S. Lahav-Baratz, O. Ben-Izhak, E. Sabo, S. Ben-Eliezer, O. Lavie, D. Ishai, A. Ciechanover, and M. Dirnfeld Decreased level of the cell cycle regulator p27 and increased level of its ubiquitin ligase Skp2 in endometrial carcinoma but not in normal secretory or in hyperstimulated endometrium Mol. Hum. Reprod., August 1, 2004; 10(8): 567 - 572. [Abstract] [Full Text] [PDF]

				T. Ouatas, D. Halverson, and P. S. Steeg Dexamethasone and Medroxyprogesterone Acetate Elevate Nm23-H1 Metastasis Suppressor Gene Expression in Metastatic Human Breast Carcinoma Cells: New Uses for Old Compounds Clin. Cancer Res., September 1, 2003; 9(10): 3763 - 3772. [Abstract] [Full Text] [PDF]

				T. Shiozawa, H.-C. Shih, T. Miyamoto, Y.-Z. Feng, J. Uchikawa, K. Itoh, and I. Konishi Cyclic Changes in the Expression of Steroid Receptor Coactivators and Corepressors in the Normal Human Endometrium J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 871 - 878. [Abstract] [Full Text] [PDF]